Cargando…
A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
Chronic enteropathy associated with SLCO2A1 gene (CEAS) is caused by loss-of-function mutations in SLCO2A1, which encodes a prostaglandin (PG) transporter. In this study, we report a sibling case of CEAS with a novel pathogenic variant of the SLCO2A1 gene. Compound heterozygous variants in SLCO2A1 w...
Autores principales: | Jimbo, Keisuke, Okuno, Toshiaki, Ohgaki, Ryuichi, Nishikubo, Kou, Kitamura, Yuri, Sakurai, Yumiko, Quan, Lili, Shoji, Hiromichi, Kanai, Yoshikatsu, Shimizu, Toshiaki, Yokomizo, Takehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652309/ https://www.ncbi.nlm.nih.gov/pubmed/33166338 http://dx.doi.org/10.1371/journal.pone.0241869 |
Ejemplares similares
-
Correction: A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
por: Jimbo, Keisuke, et al.
Publicado: (2021) -
A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter
por: Umeno, Junji, et al.
Publicado: (2015) -
Eosinophilic enteritis requiring differentiation from chronic enteropathy associated with SLCO2A1 gene: A case report
por: Kimura, Kantaro, et al.
Publicado: (2023) -
Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022) -
Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)